PlainRecalls
FDA Drug Moderate Class II Ongoing

Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.

Reported: August 6, 2025 Initiated: July 2, 2025 #D-0542-2025

Product Description

Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027

Details

Units Affected
7668 bottles
Distribution
Nationwide in the US
Location
Naples, FL

Frequently Asked Questions

What product was recalled?
Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States, Manufactured by: Lupin Limited, Goa 103 722, INDIA, NDC 68180-755-01.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 7668 bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
Which agency issued this recall?
This recall was issued by the FDA Drug on August 6, 2025. Severity: Moderate. Recall number: D-0542-2025.